Dr. Frank Harrell and Dr. C. Michael Gibson talk about the FDA’s new draft guidance on using Bayesian methods in clinical trials—and it could be a game changer.
By allowing researchers to combine prior data with new trial results, these approaches can speed up decision-making, reduce costs, and […]
